Association of baseline demographic characteristics and laboratory values with the absolute change in global LVEF
| BMC group | Placebo group | |||
| Spearman's r | p Value | Spearman's r | p Value | |
| Age | 0.072 | 0.67 | −0.067 | 0.70 |
| Gender | 0.076 | 0.66 | −0.19 | 0.26 |
| Body mass index | 0.033 | 0.86 | −0.012 | 0.95 |
| Diabetes mellitus | −0.12 | 0.49 | 0.024 | 0.89 |
| Current smoking | −0.032 | 0.86 | −0.11 | 0.55 |
| Previous angina | −0.058 | 0.74 | −0.072 | 0.68 |
| Time from AMI to thrombolysis (h) | 0.38 | 0.024 | 0.13 | 0.47 |
| LVEF (%) | −0.58 | <0.001 | −0.28 | 0.096 |
| Severity of CAD (number of vessels 1/2/3) | 0.079 | 0.65 | 0.050 | 0.77 |
| Infarct-related vessel (LAD/Cx/RCA) | −0.084 | 0.63 | 0.11 | 0.51 |
| Number of injected CD34+ cells | 0.15 | 0.39 | 0.024 | 0.91 |
| Time from AMI to cell/placebo injection (h) | −0.064 | 0.71 | −0.023 | 0.89 |
| Baseline NT-proANP (pmol/l) | 0.093 | 0.59 | −0.011 | 0.95 |
| Baseline NT-proBNP (pmol/l) | 0.33 | 0.050 | −0.25 | 0.14 |
| Baseline IL-6 (pg/ml) | 0.13 | 0.45 | 0.23 | 0.18 |
| Maximum value of CRP (mg/l) | −0.036 | 0.85 | −0.23 | 0.21 |
| Maximum value of TnI (μg/l) | −0.11 | 0.56 | −0.16 | 0.39 |
AMI, acute myocardial infarction; BMC, bone marrow-derived stem cell; CAD, coronary artery disease; CRP, C-reactive protein; Cx, circumflex coronary artery; LAD, left anterior descending coronary artery; LVEF, left ventricular ejection fraction; NT-proANP, N-terminal proatrial natriuretic peptide; NT-proBNP, N-terminal probrain natriuretic peptide; RCA, right coronary artery; TnI, troponin-I.